Characterization of an oxidoreductase from the arylamine N-acetyltransferase operon in Mycobacterium smegmatis

FEBS Journal

Volumn 278, Issue 24, 2011, Pages 4824-4832

  Evangelopoulos, Dimitrios ^a,b   Cronin, Nora ^a   Daviter, Tina ^a   Sim, Edith ^b   Keep, Nicholas H ^a   Bhakta, Sanjib ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

arylamine N acetyltransferase (NAT); Mycobacterium; NADPH; nat operon; oxidoreductase

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; DIHYDROFOLATE REDUCTASE; DIHYDROFOLIC ACID; MS0308 PROTEIN; OXIDOREDUCTASE; RECOMBINANT PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENOME; BIOINFORMATICS; COMPLEX FORMATION; CRYSTAL STRUCTURE; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; HYDROPHOBICITY; LIGAND BINDING; MYCOBACTERIUM SMEGMATIS; NAT OPERON; NONHUMAN; OLIGOMERIZATION; OPERON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STRUCTURE;

ARYLAMINE N-ACETYLTRANSFERASE; CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; MYCOBACTERIUM SMEGMATIS; NADP; OPERON; OXIDOREDUCTASES; RECOMBINANT PROTEINS; TETRAHYDROFOLATE DEHYDROGENASE;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 82755177800     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08382.x     Document Type: Article

References (36)

1. Hughes HB, (1953) On the metabolic fate of isoniazid. J Pharmacol Exp Ther 109, 444-452.
2. Upton AM, Mushtaq A, Victor TC, Sampson SL, Sandy J, Smith DM, van Helden PV, &, Sim E, (2001) Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism. Mol Microbiol 42, 309-317. (Pubitemid 32990122)
3. World Health Organization (2009) Global Tuberculosis Control: WHO Report. Global Tuberculosis Programme. World Health Organization, Geneva.
4. Payton M, Auty R, Delgoda R, Everett M, &, Sim E, (1999) Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance. J Bacteriol 181, 1343-1347. (Pubitemid 29119577)
5. Payton M, Gifford C, Schartau P, Hagemeier C, Mushtaq A, Lucas S, Pinter K, &, Sim E, (2001) Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis. Microbiology 147, 3295-3302. (Pubitemid 33150335)
6. Bhakta S, Besra GS, Upton AM, Parish T, Sholto-Douglas-Vernon C, Gibson KJ, Knutton S, Gordon S, DaSilva RP, Anderton MC, et al. (2004) Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target. J Exp Med 199, 1191-1199. (Pubitemid 38620256)
7. Anderton MC, Bhakta S, Besra GS, Jeavons P, Eltis LD, &, Sim E, (2006) Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG. Mol Microbiol 59, 181-192.
8. Lack NA, Kawamura A, Fullam E, Laurieri N, Beard S, Russell AJ, Evangelopoulos D, Westwood I, &, Sim E, (2009) Temperature stability of proteins essential for the intracellular survival of Mycobacterium tuberculosis. Biochem J 418, 369-378.
9. Van der Geize R, Yam K, Heuser T, Wilbrink MH, Hara H, Anderton MC, Sim E, Dijkhuizen L, Davies JE, Mohn WW, et al. (2007) A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages. Proc Natl Acad Sci USA 104, 1947-1952. (Pubitemid 46239884)
10. Lack NA, Yam KC, Lowe ED, Horsman GP, Owen RL, Sim E, &, Eltis LD, (2010) Characterization of a carbon-carbon hydrolase from Mycobacterium tuberculosis involved in cholesterol metabolism. J Biol Chem 285, 434-443.
11. Sim E, Sandy J, Evangelopoulos D, Fullam E, Bhakta S, Westwood I, Krylova A, Lack N, &, Noble M, (2008) Arylamine N-acetyltransferases in mycobacteria. Curr Drug Metab 9, 510-519. (Pubitemid 352025182)
12. Sirawaraporn W, Sirawaraporn R, Chanpongsri A, Jacobs WR Jr, &, Santi DV, (1991) Purification and characterization of dihydrofolate reductase from wild-type and trimethoprim-resistant Mycobacterium smegmatis. Exp Parasitol 72, 184-190.
13. Krissinel E, &, Henrick K, (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372, 774-797. (Pubitemid 47321791)
14. Krissinel E, &, Henrick K, (2004) Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D BiolCrystallogr 60, 2256-2268. (Pubitemid 41742778)
15. Chatwell L, Krojer T, Fidler A, Romisch W, Eisenreich W, Bacher A, Huber R, &, Fischer M, (2006) Biosynthesis of riboflavin: structure and properties of 2,5-diamino-6-ribosylamino-4(3H) -pyrimidinone 5′-phosphate reductase of Methanocaldococcus jannaschii. J Mol Biol 359, 1334-1351. (Pubitemid 43903500)
16. Zhang Z, Rajagopalan PT, Selzer T, Benkovic SJ, &, Hammes GG, (2004) Single-molecule and transient kinetics investigation of the interaction of dihydrofolate reductase with NADPH and dihydrofolate. Proc Natl Acad Sci USA 101, 2764-2769. (Pubitemid 38327685)
17. McElheny D, Schnell JR, Lansing JC, Dyson HJ, &, Wright PE, (2005) Defining the role of active-site loop fluctuations in dihydrofolate reductase catalysis. Proc Natl Acad Sci USA 102, 5032-5037.
18. Dams T, Auerbach G, Bader G, Jacob U, Ploom T, Huber R, &, Jaenicke R, (2000) The crystal structure of dihydrofolate reductase from Thermotoga maritima: molecular features of thermostability. J Mol Biol 297, 659-672.
19. Klon AE, Heroux A, Ross LJ, Pathak V, Johnson CA, Piper JR, &, Borhani DW, (2002) Atomic structures of human dihydrofolate reductase complexed with NADPH and two lipophilic antifolates at 1.09 Å and 1.05 Å resolution. J Mol Biol 320, 677-693. (Pubitemid 34753988)
20. Chen SC, Chang YC, Lin CH, &, Liaw SH, (2006) Crystal structure of a bifunctional deaminase and reductase from Bacillus subtilis involved in riboflavin biosynthesis. J Biol Chem 281, 7605-7613.
21. Stenmark P, Moche M, Gurmu D, &, Nordlund P, (2007) The crystal structure of the bifunctional deaminase/reductase RibD of the riboflavin biosynthetic pathway in Escherichia coli: implications for the reductive mechanism. J Mol Biol 373, 48-64. (Pubitemid 47390708)
22. Graupner M, Xu H, &, White RH, (2002) The pyrimidine nucleotide reductase step in riboflavin and F(420) biosynthesis in archaea proceeds by the eukaryotic route to riboflavin. J Bacteriol 184, 1952-1957. (Pubitemid 34275539)
23. Graupner M, Xu H, &, White RH, (2002) Characterization of the 2-phospho-l-lactate transferase enzyme involved in coenzyme F(420) biosynthesis in Methanococcus jannaschii. Biochemistry 41, 3754-3761. (Pubitemid 34224689)
24. Haase I, Mortl S, Kohler P, Bacher A, &, Fischer M, (2003) Biosynthesis of riboflavin in archaea. 6,7-Dimethyl-8-ribityllumazine synthase of Methanococcus jannaschii. Eur J Biochem 270, 1025-1032. (Pubitemid 36315346)
25. Cheeseman P, Toms-Wood A, &, Wolfe RS, (1972) Isolation and properties of a fluorescent compound, factor 420, from Methanobacterium strain M.o.H. J Bacteriol 112, 527-531.
26. Purwantini E, &, Daniels L, (1996) Purification of a novel coenzyme F420-dependent glucose-6-phosphate dehydrogenase from Mycobacterium smegmatis. J Bacteriol 178, 2861-2866.
27. Boshoff HI, &, Barry CE III, (2005) Tuberculosis-metabolism and respiration in the absence of growth. Nat Rev 3, 70-80. (Pubitemid 40028470)
28. Manjunatha UH, Boshoff H, Dowd CS, Zhang L, Albert TJ, Norton JE, Daniels L, Dick T, Pang SS, &, Barry CE III, (2006) Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 103, 431-436. (Pubitemid 43122418)
29. Kabsch W, (2010) XDS. Acta Crystallogr D Biol Crystallogr 66, 125-132.
30. Collaborative Computational Project, Number 4 (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50, 760-763.
31. Keegan RM, &, Winn MD, (2008) MrBUMP: an automated pipeline for molecular replacement. Acta Crystallogr D Biol Crystallogr 64, 119-124. (Pubitemid 350308685)
32. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, &, Read RJ, (2007) Phaser crystallographic software. J Appl Crystallogr 40, 658-674. (Pubitemid 47080256)
33. Emsley P, Lohkamp B, Scott WG, &, Cowtan K, (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66, 486-501.
34. Murshudov GN, Vagin AA, &, Dodson EJ, (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53, 240-255. (Pubitemid 27235885)
35. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213-221.
36. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, &, Ferrin TE, (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25, 1605-1612.